Cargando...
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling
Endogenous satiety hormones provide an attractive target for obesity drugs. Glucagon causes weight loss by reducing food intake and increasing energy expenditure. To further understand the cellular mechanisms by which glucagon and related ligands activate the glucagon receptor (GCGR), we investigate...
Gardado en:
| Publicado en: | Endocrinology |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Endocrine Society
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5551549/ https://ncbi.nlm.nih.gov/pubmed/28586439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2016-1755 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|